Press Releases

Darius Šulnis, CEO of Invalda INVL, and Paulius Žurauskas, CEO of INVL Asset Management, at the webinar spoke about the note issue, which is currently under public offering, and its objectives.

The recording of the webinar is provided on YouTube account of Invalda INVL group https://youtu.be/XQT0wN_0t1w

The person authorised to provide additional information: Darius Šulnis CEO of Invalda INVL E-mail  [email protected]

Boston, June 06, 2024 (GLOBE NEWSWIRE) -- Global entrepreneurship education nonprofit Network for Teaching Entrepreneurship (NFTE) has named four local student businesses as the winners of its annual New England Regional Youth Entrepreneurship Challenge. The young entrepreneurs distinguished themselves through innovative business ideas, which they will present at the national finals in New York on Oct. 10 to compete for the National Champion title and cash prizes.

RIYADH, Saudi Arabia, June 6, 2024 /PRNewswire/ -- A team of Saudi doctors has successfully conducted a landmark separation surgery on Filipino conjoined twins, Akhizah and Ayeesha, granting them a new lease on life and marking another milestone in the Kingdom's renowned Saudi Conjoined Twins Programme.

Akhizah and Ayeesha, just 16 months old and born... (continue reading...)

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 6, 2024) - On Thursday, June 6, 2024, Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) was informed by medac, licensor of Medexus's commercialization rights to treosulfan, that the US Food and Drug Administration has accepted for review medac's April 2024 resubmission of the New Drug Application for treosulfan. Medexus expects that the FDA will complete its review of the treosulfan NDA and issue a decision... (continue reading...)

7276118.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION